Skip to main content
. 2017 Feb 8;18(2):349. doi: 10.3390/ijms18020349

Table 3.

Published studies on inhaled FGA loxapine in the treatment of agitation in psychiatric disorders.

Authors Year Study Sample Study Design Number of Subject Study Aims Dose (mg/Day) Main Findings
Allen et al. 2011 Agitated patients with schizophrenia Phase II, randomized, double-blind, placebo-controlled study 129 To evaluate inhaled loxapine for acute treatment of agitation in schizophrenia Single inhalation of 5 or 10 mg of loxapine or placebo Inhaled loxapine was generally safe and well tolerated and produced rapid improvement in agitated patients with psychotic disorders
Lesem et al. 2011 Agitated patients with schizophrenia Phase III, randomised, double-blind, placebo-controlled, parallel-group study 344 To evaluate inhaled loxapine for acute treatment of agitation in schizophrenia Two or three doses of inhaled loxapine (5 or 10 mg) or placebo Inhaled loxapine was a well-tolerated and effective treatment of agitation in schizophrenia
Kwentus et al. 2012 Agitated patients with bipolar I disorder Phase III, randomized, double blind, placebo-controlled, parallel group inpatient study 314 To evaluate inhaled loxapine for the acute treatment of agitation in patients with bipolar I disorder Inhaled loxapine 5 mg or 10 mg or inhaled placebo Inhaled loxapine provided a rapid, non-injection, well-tolerated acute treatment for agitation in patients with bipolar I disorder
Krüger et al. 2015 Agitated patients with borderline personality disorder Case series 5 To evaluate inhaled loxapine for emergency treatment of agitated patients with borderline personality disorder Inhaled loxapine 10 mg Inhaled loxapine was safe, well tolerated and produced rapid improvement in agitated patients with borderline personality disorder
Roncero et al. 2016 Patients with dual diagnosis Retrospective case Series 14 Efficacy of inhaled loxapine on episodes of psychotic agitation in patients with dual diagnosis Inhaled loxapine 10 mg Inhaled loxapine was rapid, effective, and well accepted in all dual-diagnosis patients presenting with acute agitation in the emergency setting